Background: Aortic coarctation (AC) is most commonly identified in pediatric patients; however, adults can present with late sequelae of untreated coarctation or complications of prior open repair. To date, there are limited data about the role of thoracic endovascular aortic repair (TEVAR) in this group of patients. The purpose of this analysis was to describe our experience with management of adult coarctation patients using TEVAR.
Results: A total of 21 patients were identified (median age, 46 years [range, 33-71 years]; 67% male [n ¼ 14] ). Nine patients (43%) were treated for symptomatic primary (n ¼ 6) or recurrent (n ¼ 3) coarctation. Other indications included degenerative thoracic aneurysm (n ¼ 6), pseudoaneurysm (n ¼ 4), and dissection (n ¼ 2). Technical success was 100% (95% confidence interval [CI] , 84%-100%). No 30-day mortality or paraplegia events occurred; however, two patients (10%) experienced postoperative nondisabling stroke. In primary or recurrent coarctation patients with available computed tomography imaging (n ¼ 8 of 9), nominal stent graft diameters were achieved proximal and distal to the coarctation (range, À0.4 to À1.2 mm of desired final stent diameter). Specific to the coarctation site, there was a significant increase in aortic diameter after TEVAR (before stenting, 11.5 [95% CI, after stenting, 15 [95% CI, .7] mm; P ¼ .004). Concurrently, systolic arterial blood pressure at time of discharge was significantly lower (before stenting: 147 mm Hg; 95% CI, 137-157 mm Hg; after stenting: 124 mm Hg; 95% CI, 118-134 mm Hg; P ¼ .02). For all patients, median clinical followup time was 8 months (interquartile range, 3-13 months; range, 1-106 months). Three endoleaks were detected, all of which were type II related to left (n ¼ 2) or aberrant (n ¼ 1) subclavian arteries. Four patients (19%) underwent reintervention (median time, 7 months; range, 2-12 months), with three of four being subclavian artery embolization; one was an aortic root replacement for ascending aneurysm with bicuspid aortic valve. One-year freedom from reintervention was 78% 6 9% (95% CI, 42%-92%). The 1-and 3-year survival was 95% 6 5% (95% CI, 71%-99%). One late death was related to complications from pre-existing congenital heart disease.
Conclusions: Adult AC patients can be treated safely with TEVAR, and the annular constriction of an AC can be successfully dilated by the stent graft. Given these findings, a greater number of patients with longer term follow-up is warranted to further define the role of TEVAR in the management of adult AC patients. ( The purpose of this analysis was to describe our experience with TEVAR in adults presenting with late sequelae of untreated coarctation or complications of the index repair.
METHODS
The University of Florida Institutional Review Board approved this study, and the requirement for patient consent was waived (No. 510-2015) .
Database and patient cohort. This is a retrospective single-center review of a prospectively maintained endovascular aortic registry. All TEVAR procedures were reviewed (n ¼ 985), and adult patients (aged $18 years) treated with TEVAR for primary coarctation or late No pediatric TEVAR cases (aged #18 years) for an AC or complication of prior open AC repair were identified in the registry. Elective and nonelective presentations, including emergency and ruptured indications, were analyzed. Open surgical repair of adult AC patients and complications after coarctation repair were excluded. The electronic medical record was reviewed to abstract demographics, comorbidities, procedurespecific details, reinterventions, and complications. The patient's death was confirmed using the Social Security Death Master File.
End points and definitions. Primary end points of the study included 30-day mortality and in-hospital complications. Secondary end points included technical success, diameter changes of the stenotic aortic segment over time, reintervention, and survival. Primary coarctation was defined as a native AC that was not associated with prior open repair. Secondary or recurrent coarctation was defined as an AC that occurred after the index open AC repair.
Zones of endograft attachment were defined according to current reporting standards for TEVAR, 18 and technical success was defined as successful exclusion of the aneurysm, adequate coverage of the dissection, or sufficient treatment of the stenosis at the site of coarctation on completion angiography. Adequate treatment of the coarctation was confirmed by <10 mm Hg systolic gradient with intra-aortic manometry. Technical success for AC treatment was determined by lack of residual hemodynamic gradient and exclusion of concurrent aortic disease. Comorbidities were defined on the basis of previously published definitions from the Society for Vascular Surgery. 18 Reintervention was defined as any 
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